Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

69 results about "Arterial stents" patented technology

Percutaneous aorta bracket or aortic valve bracket system with far-end protection

The invention relates to a percutaneous aorta bracket or an aortic valve bracket system with far-end protection, which comprises an outer sheath pipe, a limit pipe and an inner sheath pipe, wherein the inner sheath pipe is arranged in the limit pipe; the limit pipe is arranged in the outer sheath pipe; the inner sheath pipe is a hollow pipe; three handles are respectively arranged at the near ends of the inner sheath pipe, the limit pipe and the outer sheath pipe. The system further comprises a protector and a protector limiting device, wherein the protector is arranged between the far end parts of the outer sheath pipe and the inner sheath pipe; the near end of the protector is connected with the far end of the protector limiting device; the protector limiting device is arranged between the limit pipe and the outer sheath pipe; the near end of the protector limiting device is fixedly connected with the far end of the limit pipe; a retracing conducting wire is fixedly connected with the near end of the protector; the far end part of the end retracing conducting wire is arranged on the outer side of the outer sheath pipe. The system provided by the invention effectively prevents impurities such as valve leaflet tissue or atheromatous plaque touched to fall due to follow-up operations from entering into vessels such as carotid, remarkably reduces the complexity and the difficulty of the operation, and shortens the operation time and the recovery time after the operation.
Owner:NINGBO JENSCARE BIOTECHNOLOGY CO LTD

Method for reducing incidence of in-stent restenosis and special stainless steel material thereof

ActiveCN102618796AReduce the incidence of restenosisReduce restenosis functionStentsSurgeryCoronary arteriesStent implantation
The invention relates to the field of coronary stents, specifically to a method for reducing the incidence of in-stent restenosis and its special stainless steel material. The method of the invention adds a proper amount of copper element (2.0-6.0% by weight) into the common clinical coronary stent material 316L stainless steel, and conducts special heat treatment so as to make the copper separated in a copper-rich phase out of the stainless steel substrate. The stent is enabled to continuously release trace amounts of copper ions in a clinical environment, and the coronary stent is endowed with an anti-restenotic function, thus effectively reducing the incidence of restenosis after stent implantation. With a unique function of reducing the in-stent restenosis phenomenon caused by stent implantation into a coronary artery, the 316L type copper-containing stainless steel of the invention is conducive to solve clinical problems such as high incidence of in-stent restenosis after implantation of existing stainless steel coronary stents, and can be applied in coronary stents and other clinical medicine fields, thus providing a new idea and material basis for development and application of coronary stents.
Owner:蔻沛斯蒂(浙江)医疗器械有限公司

Ascending aorta stent anchored by innominate artery for dissection, and delivery system

ActiveCN109172043ASecurity anchoring methodNo entry into the false cavityStentsBlood vesselsAortic dissectionThird aortic arch
The invention provides an ascending aorta repair stent anchored by innominate artery, comprising an ascending aorta stent segment and an innominate artery stent segment, wherein an innominate artery portion of the stent is first released and a body portion is then released; the distal end opening of the body portion facing the distal end of the aortic arch lumen, and the body portion of the stentcovers the dissection at the primary rupture of the ascending aorta. When the release is completed, the main body terminates above the junction of the sinus canal. The longitudinal beam structure is made of a temperature-dependent shape memory metal material extending to the great curvature side of the aortic arch of the innominate artery and to the minor curvature side of the aortic arch, and isreleased so as to satisfy the individualized ascending aortic anatomical arc of different patients to abut against the aortic wall. The stent is anchored only according to the special anatomical shapeof the ascending aorta and the innominate artery and the memory metal longitudinal beam structure. Used in patients with type A aortic dissection in the acute phase of surgical contraindication whenwaiting for the transitional phase of surgery for patients with high surgical risk of acute type A aortic dissection to provide follow-up surgical treatment opportunities.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

Method for reducing incidence of in-stent restenosis and special stainless steel material thereof

ActiveCN102618796BReduce the incidence of restenosisReduce restenosis functionStentsSurgeryCoronary arteriesStent implantation
The invention relates to the field of coronary stents, specifically to a method for reducing the incidence of in-stent restenosis and its special stainless steel material. The method of the invention adds a proper amount of copper element (2.0-6.0% by weight) into the common clinical coronary stent material 316L stainless steel, and conducts special heat treatment so as to make the copper separated in a copper-rich phase out of the stainless steel substrate. The stent is enabled to continuously release trace amounts of copper ions in a clinical environment, and the coronary stent is endowed with an anti-restenotic function, thus effectively reducing the incidence of restenosis after stent implantation. With a unique function of reducing the in-stent restenosis phenomenon caused by stent implantation into a coronary artery, the 316L type copper-containing stainless steel of the invention is conducive to solve clinical problems such as high incidence of in-stent restenosis after implantation of existing stainless steel coronary stents, and can be applied in coronary stents and other clinical medicine fields, thus providing a new idea and material basis for development and application of coronary stents.
Owner:蔻沛斯蒂(浙江)医疗器械有限公司

Functions and application of responsive to centrifugal force and shear stress gene 1 (RECS1) to treatment of restenosis after vascular injury

ActiveCN104198697APromote restenosisPro-restenosisGenetic material ingredientsSurgeryCell phenotypeDisease
The invention discloses functions and application of responsive to centrifugal force and shear stress gene 1 (RECS1) to treatment of restenosis after vascular injury. An RECS1 knockout mouse and a wild type mouse are taken as experimental subjects, and detection on mouse internal membrane regeneration, vessel wall cell proliferation level and smooth muscle cell phenotype transformation is carried out by a vascular injury model. Detection results prove that by virtue of RECS1 knockout, internal membrane regeneration and cell proliferation can be obviously inhibited, and smooth muscle cells are inhibited to be transformed into synthetic phenotype from contractile phenotype. Therefore, the functions of the RECS1 to the restenosis after vascular injury are mainly embodied in that internal membrane regeneration, cell proliferation and smooth muscle cell phenotype transformation are promoted by the RECS1. Aiming at the functions of the RECS1, the RECS1 can be used as a drug target for screening medicines for preventing, relieving and/or treating the disease of restenosis after vascular injury; an inhibitor of the RECS1 can be used for preparing medicines and arterial stents for preventing, relieving and/or treating the restenosis after vascular injury.
Owner:武汉惠康基因科技有限公司

Iron-based alloy renal artery stent

The invention discloses an iron-based alloy renal artery stent, and relates to the technical field of medical instruments. The iron-based alloy renal artery stent comprises a first end socket and an intermediate tube, wherein a connection large head is fixedly connected with one end of the first end socket, an inner buckle is fixedly connected with an inner wall of the connection large head, bothends of the intermediate tube are fixedly connected with connection small heads, outer buckles are fixedly connected with outer walls of the connection small heads, the inner buckle and the outer buckles are matched, and the connection large head is fixedly connected with the outer buckles on the connection small heads through the inner buckle. According to the iron-based alloy renal artery stent,by arranging the first end socket and a second end socket, after the first end socket and the second end socket, which are conical, are fixedly connected with the intermediate tube, the intermediatetube can always located in a hemadostenosis position, and due to the fact that the first end socket and the second end socket are conical, nether the first end socket nor the second end socket can gothrough the hemadostenosis position, so that the purposes of fixing the intermediate tube and preventing movement of the iron-based alloy renal artery stent in a blood vessel are achieved.
Owner:郑州美港高科生物科技有限公司

Coronary artery stent implantation operation image operation platform

The invention discloses a coronary artery stent implantation surgery image operation platform which comprises a supporting table, a rotating groove is formed in the supporting table, a rotating rod is rotationally connected to the rotating groove, a supporting rod is fixedly installed at the upper end of the rotating rod, a lifting groove is formed in the supporting rod, a lifting rod is slidably connected into the lifting groove, and a rotating shaft is arranged in the lifting rod. And moving blocks are fixedly mounted on the left side and the right side of the lifting rod correspondingly, moving grooves are formed in the left side and the right side of the lifting groove correspondingly, the two moving grooves are matched with the two moving blocks correspondingly, and sliding rods are fixedly mounted on the two moving blocks correspondingly. The medical image display device has the advantages that doctors standing at different positions can clearly check images in the body of a patient, so that the success rate of an operation can be improved to a certain extent, the mounting height and the vertical angle of the display screen can be adjusted according to needs, the doctors can better clearly check the images on the display screen, and the operation efficiency is improved. And the application range is wider.
Owner:PINGMEI SHENMA MEDICAL GRP GENERAL HOSPITAL

A cross-supported helical popliteal artery stent and its manufacturing method

ActiveCN113065264BImprove flexibilityAdapt to the complex bending deformation of the popliteal arteryGeometric CADStentsPopliteal Artery BranchAxial compression
The invention discloses a cross-supporting spiral popliteal artery stent, which comprises support rings and connecting rods, the support rings and the connecting rods are alternately connected, and the two ends of the stent are support rings. Among them, the support ring includes a clockwise helix and a counterclockwise helix, and multiple clockwise helixes and multiple counterclockwise helixes are arranged at equal intervals on a virtual cylindrical surface with a radius R, and multiple clockwise helixes and multiple The counterclockwise helical lines intersect; the connecting rod includes a right-handed helical line, and a plurality of right-handed helical lines are arranged at equal intervals on the cylindrical surface, and a plurality of right-handed helical lines are connected with multiple intersection points on the circumference of the bottom surface of the support ring; the support ring is connected with the The rod has a winding height ratio of 1 or less. The cross-supported helical popliteal artery stent has excellent flexibility, sufficient adaptability to axial compression, sufficient torsion capacity, and sufficient radial support force. The stent provides support for blood vessels and is not prone to radial compression under load.
Owner:SICHUAN UNIV

Pulmonary artery stent convenient to control, and pulmonary artery valve replacement device

The invention discloses a pulmonary artery stent convenient to control. The pulmonary artery stent convenient to control comprises a tubular supporting net frame, fixing pieces, a flowing out stent and at least two groups of aorta stents, wherein the supporting net frame consists of continuous regular hexagon rotating units, and top points located at two ends of the supporting net frame, of the rotating units are connecting points; each aorta stent comprises a supporting strip and four auxiliary strips, two ends of each supporting strip are respectively connected with two connecting points which are the farthest from each other, the four auxiliary strips are connected with four connecting points in the middle in a one-to-one correspondence, one end departing from the connecting points, ofeach auxiliary strip and the corresponding supporting strip are connected to one point, and the corresponding fixing piece is located at the connecting position of each supporting strip and the corresponding auxiliary strip; and the flowing out stent is located at the other end of the supporting net frame. According to the pulmonary artery stent convenient to control disclosed by the invention, the connecting lines between rotating units in the pulmonary artery stent convenient to control are long, every two adjacent rotating units rotate along the corresponding connecting line, during rotation, the rotation direction is stable and reliable, and accidental situations appearing in a mounting process can be effectively avoided and reduced.
Owner:SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products